Centene To Exit Medicare Advantage In Six States

Centene plans to exit the Medicare Advantage (MA) marketplace for 2025 in Alabama, Massachusetts, New Hampshire, New Mexico, Rhode Island, and Vermont. This decision affects Centene’s Wellcare MA line. However, Wellcare will continue to offer Medicare Prescription Drug Plans (PDPs) in these states. The decision does not affect Centene’s Marketplace or Medicaid contracts in these markets.

Wellcare is a wholly owned subsidiary of Centene Corporation, a large health care insurer. For more than 20 years, Wellcare has offered a range of Medicare products, including Medicare Advantage and Medicare PDPs, which offer affordable coverage beyond Original Medicare.

This was . . .